目录产品 » Pembrolizumab Immunogenicity Kit (Bridging ELISA)
Manual
SDS
COAs

Pembrolizumab Immunogenicity Kit (Bridging ELISA)

GenScript Pembrolizumab Immunogenicity Kit (Bridging ELISA) is used for detection of anti-Pembrolizumab antibody in serum and plasma samples. It is a validated bridging immunoassay based on the FDA, EMA and NMPA Immunogenicity Guidelines. The kit has been proved to be highly sensitive, specific, and free from matrix effect in the validation study.
￥4980
L00971

产品简介
Linearity Range 1.56-50 ng/mL
Sensitivity 1.56 ng/ml
Precision Intra-assay≤10%
Inter-assay≤15%
Accuracy 80%-120%
Standard 100 µg/mL of anti-Pembrolizumab antibody
Assay Temperature 37 ℃
Assay Time 2.5 h
Storage The unopened kit is stable for at least 12 months from the date of manufacture at 2°C to 8°C, and the opened kit is stable for up to 1 month from the date of opening at 2°C to 8°C.
Kit Contents
Component Quantity/Size Part No.
Capture Plate 1 plate K1-80
Standard Stock 1 vial (50 μL) K1-10
100×Biotin Pembrolizumab 1 vial (100 μL) K1-20
Streptavidin-HRP 1 bottle (12 mL) K1-30
Sample Dilution Buffer 1 bottle (60 mL) K1-60
20×Wash Solution 1 bottle (60 mL) B-A1-71
Stop Solution 1 bottle (6 mL) B-A1-50
TMB Solution 1 bottle (12 mL) B-A1-40
Plate Sealer 2 pieces N/A
返回

图例
Pembrolizumab Immunogenicity Kit (Bridging ELISA)

Figure 1: Pembrolizumab Immunogenicity Kit (Bridging ELISA) standard curve. »

Pembrolizumab Immunogenicity Kit (Bridging ELISA)

Figure 2. MRD analysis of the Kit »

Pembrolizumab Immunogenicity Kit (Bridging ELISA)

»

Pembrolizumab Immunogenicity Kit (Bridging ELISA)

»

Pembrolizumab Immunogenicity Kit (Bridging ELISA)

»

<
>

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.